Fox Run Management, L.L.C. Viatris Inc Transaction History

Fox Run Management, L.L.C.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$9.2 - $12.26 $223,127 - $297,341	24,253 Added 91.31%	50,813 $488,000
Q4 2022 Feb 07, 2023	BUY	$8.72 - $11.56 $231,603 - $307,033	26,560 New	26,560 $295,000
Q2 2022 Aug 12, 2022	BUY	$9.95 - $12.27 $249,943 - $308,222	25,120 New	25,120 $263,000
Q1 2022 May 10, 2022	SELL	$9.81 - $15.4 $479,473 - $752,690	-48,876 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$12.09 - $14.68 $139,022 - $168,805	11,499 Added 30.76%	48,876 $661,000
Q3 2021 Nov 15, 2021	SELL	$13.25 - $15.13 $36,424 - $41,592	-2,749 Reduced 6.85%	37,377 $506,000
Q2 2021 Aug 05, 2021	BUY	$12.97 - $16.15 $308,154 - $383,707	23,759 Added 145.16%	40,126 $573,000
Q1 2021 May 17, 2021	BUY	$13.59 - $18.54 $222,427 - $303,444	16,367 New	16,367 $229,000

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fox Run Management, L.L.C. with notifications on news.